Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:00 pm Purchase | 2025-09-30 | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I, L.P. | 2,957,957 8.900% | 2,957,957 (New Position) | Filing History |
| 2024-11-14 3:36 pm Unchanged | 2024-11-14 | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-02 4:30 pm Unchanged | 2024-10-02 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-09-06 4:59 pm Unchanged | 2024-09-06 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-04-16 09:15 am Unchanged | 2024-04-16 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-02 09:20 am Unchanged | 2024-02-02 | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 08:22 am Unchanged | 2023-02-14 | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-09 5:00 pm Unchanged | 2023-01-09 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 5:02 pm Unchanged | 2022-02-10 | 13G | Galecto, Inc. GLTO | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 5:00 pm Unchanged | 2022-02-10 | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-11-01 5:16 pm Unchanged | 2021-11-01 | 13G | NeuroPace, Inc. NPCE | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-09-03 5:16 pm Unchanged | 2021-09-03 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-06-28 4:32 pm Unchanged | 2021-06-28 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I, L.P. | 0 0.000% | 0 (Unchanged) | Filing |